Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gastrofensin AN 5 free base, is an antiulcer agent. a 4-phenyl-tetrahydroisoquinoline derivative.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Gastrofensin AN 5 free base, is an antiulcer agent. a 4-phenyl-tetrahydroisoquinoline derivative. |
In vivo | Gastrofensin AN 5 effectively suppresses ulcer formation across all tested models, demonstrating significant antiulcer activity even at a low dose of 0.100 mg/kg. The effectiveness of Gastrofensin AN 5 in inhibiting ulceration enhances with dosage increments, peaking at a dose of 1 mg/kg (86.15%). Comparative analyses with Ranitidine and Cimetidine, on identical experimental gastric ulcer models, reveal that Gastrofensin AN 5's antiulcer efficacy substantially surpasses those of the aforementioned drugs. |
Molecular Weight | 344.84 |
Formula | C19H21ClN2O2 |
CAS No. | 89845-16-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gastrofensin AN 5 free base 89845-16-9 Others Gastrofensin AN 5 inhibitor inhibit